Anna Borissova

518 total citations
23 papers, 218 citations indexed

About

Anna Borissova is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Anna Borissova has authored 23 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 6 papers in Psychiatry and Mental health and 5 papers in Cognitive Neuroscience. Recurrent topics in Anna Borissova's work include Cannabis and Cannabinoid Research (17 papers), Substance Abuse Treatment and Outcomes (5 papers) and Prenatal Substance Exposure Effects (4 papers). Anna Borissova is often cited by papers focused on Cannabis and Cannabinoid Research (17 papers), Substance Abuse Treatment and Outcomes (5 papers) and Prenatal Substance Exposure Effects (4 papers). Anna Borissova collaborates with scholars based in United Kingdom, Australia and Bulgaria. Anna Borissova's co-authors include Valerie H. Curran, Will Lawn, Claire Mokrysz, Tom P. Freeman, Kat Petrilli, Matthew B. Wall, Celia J. A. Morgan, Beth Marsh, Meryem Grabski and Michael Bloomfield and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Anna Borissova

21 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Borissova United Kingdom 10 134 70 47 43 41 23 218
Rayyan Zafar United Kingdom 9 113 0.8× 92 1.3× 48 1.0× 36 0.8× 24 0.6× 16 256
R. Vecchiotti Italy 7 58 0.4× 129 1.8× 48 1.0× 118 2.7× 22 0.5× 13 349
Alexandre Rafael de Mello Schier Brazil 7 260 1.9× 69 1.0× 72 1.5× 44 1.0× 50 1.2× 10 370
Tanya Ramey United States 8 126 0.9× 54 0.8× 26 0.6× 114 2.7× 39 1.0× 13 370
Naji C. Salloum United States 9 222 1.7× 40 0.6× 59 1.3× 64 1.5× 38 0.9× 11 315
Matteo Caloro Italy 8 51 0.4× 61 0.9× 45 1.0× 106 2.5× 26 0.6× 14 243
Nicholas C. Glodosky United States 8 195 1.5× 61 0.9× 80 1.7× 21 0.5× 26 0.6× 16 277
Beth Marsh United Kingdom 6 86 0.6× 87 1.2× 37 0.8× 27 0.6× 15 0.4× 6 177
André Elferink Netherlands 9 70 0.5× 56 0.8× 22 0.5× 79 1.8× 23 0.6× 16 278
Anahita Bassir Nia United States 10 156 1.2× 140 2.0× 60 1.3× 59 1.4× 33 0.8× 23 310

Countries citing papers authored by Anna Borissova

Since Specialization
Citations

This map shows the geographic impact of Anna Borissova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Borissova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Borissova more than expected).

Fields of papers citing papers by Anna Borissova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Borissova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Borissova. The network helps show where Anna Borissova may publish in the future.

Co-authorship network of co-authors of Anna Borissova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Borissova. A scholar is included among the top collaborators of Anna Borissova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Borissova. Anna Borissova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Freeman, Tom P., Daniel L. Hall, Claire Mokrysz, et al.. (2024). The effects of acute cannabis with and without cannabidiol on neural reward anticipation in adults and adolescents. Neuroscience Applied. 3. 103989–103989. 2 indexed citations
3.
Freeman, Tom P., Claire Mokrysz, Anna Borissova, et al.. (2024). Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks. Neuropsychopharmacology. 49(10). 1640–1651. 10 indexed citations
4.
Lees, Rachel, Will Lawn, Kat Petrilli, et al.. (2024). Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European Archives of Psychiatry and Clinical Neuroscience. 275(2). 397–406. 6 indexed citations
5.
6.
Lawn, Will, Claire Mokrysz, Tom P. Freeman, et al.. (2023). Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults. Journal of Psychopharmacology. 37(9). 904–919. 6 indexed citations
7.
Lawn, Will, Claire Mokrysz, Anna Borissova, et al.. (2023). The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment. Addiction. 118(7). 1282–1294. 24 indexed citations
8.
9.
Borissova, Anna & James Rucker. (2023). The development of psilocybin therapy for treatment-resistant depression: an update. BJPsych Bulletin. 48(1). 38–44. 5 indexed citations
10.
Freeman, Tom P., Daniel L. Hall, Claire Mokrysz, et al.. (2022). The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 8(2). 219–229. 7 indexed citations
11.
Lawn, Will, Claire Mokrysz, Rachel Lees, et al.. (2022). The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls. Psychopharmacology. 239(5). 1629–1641. 9 indexed citations
12.
Mokrysz, Claire, Tom P. Freeman, Matthew B. Wall, et al.. (2022). Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls. Neuropsychopharmacology. 47(11). 1976–1983. 15 indexed citations
13.
Borissova, Anna, Elizabeth R. Aston, Rachel Lees, et al.. (2022). Age differences in the behavioural economics of cannabis use: Do adolescents and adults differ on demand for cannabis and discounting of future reward?. Drug and Alcohol Dependence. 238. 109531–109531. 6 indexed citations
14.
Mokrysz, Claire, Tom P. Freeman, Vincent Valton, et al.. (2022). Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls. The International Journal of Neuropsychopharmacology. 26(1). 9–19. 12 indexed citations
15.
Lawn, Will, Claire Mokrysz, Rachel Lees, et al.. (2022). The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls. Journal of Psychopharmacology. 36(12). 1350–1361. 24 indexed citations
16.
Lawn, Will, Claire Mokrysz, Daniel L. Hall, et al.. (2021). Do adolescents and adults differ in the acute subjective, psychotomimetic, and memory-impairing effects of cannabis?. OSF Preprints (OSF Preprints). 1 indexed citations
17.
Lawn, Will, Claire Mokrysz, Rachel Lees, et al.. (2021). P.0320 Depression, anxiety, psychotic-like symptoms and addiction in adolescents and adults who do and do not use cannabis. European Neuropsychopharmacology. 53. S232–S233. 1 indexed citations
18.
Grabski, Meryem, Anna Borissova, Beth Marsh, Celia J. A. Morgan, & Valerie H. Curran. (2020). Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review. Behavioural Brain Research. 392. 112629–112629. 34 indexed citations
19.
Lawn, Will, Claire Mokrysz, Anna Borissova, et al.. (2019). cannTEEN: How does long-term cannabis use affect teenagers' and adults' cognition, mental health and brains?. 1 indexed citations
20.
Zacharieva, Sabina, E. Nachev, Zdravko Kamenov, et al.. (2003). Effect of amlodipine and hormone replacement therapy on bloodpressure and bone markers in menopause. Methods and Findings in Experimental and Clinical Pharmacology. 25(3). 209–209. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rayyan Zafar Breakdown of academic impact, for papers by R. Vecchiotti Breakdown of academic impact, for papers by Alexandre Rafael de Mello Schier Breakdown of academic impact, for papers by Tanya Ramey Breakdown of academic impact, for papers by Naji C. Salloum Breakdown of academic impact, for papers by Matteo Caloro Breakdown of academic impact, for papers by Nicholas C. Glodosky Breakdown of academic impact, for papers by Beth Marsh Breakdown of academic impact, for papers by André Elferink Breakdown of academic impact, for papers by Anahita Bassir Nia
Rankless by CCL
2026